Enzo Biochem - 39 Year Stock Price History | ENZ

Historical daily share price chart and data for Enzo Biochem since 1980 adjusted for splits. The latest closing stock price for Enzo Biochem as of October 18, 2019 is 3.23.
  • The all-time high Enzo Biochem stock closing price was 122.00 on January 21, 2000.
  • The Enzo Biochem 52-week high stock price is 4.46, which is 38.1% above the current share price.
  • The Enzo Biochem 52-week low stock price is 2.32, which is 28.2% below the current share price.
  • The average Enzo Biochem stock price for the last 52 weeks is 3.38.
Enzo Biochem Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2019 3.4480 2.8000 4.3100 2.5400 3.2300 16.19%
2018 5.2278 8.2500 8.3600 2.4600 2.7800 -65.89%
2017 9.2622 7.1400 11.7900 6.4000 8.1500 17.44%
2016 5.5990 4.6900 7.4800 4.0600 6.9400 54.22%
2015 3.3382 4.4500 4.9500 2.4300 4.5000 1.35%
2014 4.4767 2.9200 6.0800 2.6900 4.4400 52.05%
2013 2.4717 2.7500 3.1000 1.9400 2.9200 8.15%
2012 2.2276 2.3700 3.0500 1.4600 2.7000 20.54%
2011 3.5622 5.5000 5.7900 1.9900 2.2400 -57.58%
2010 4.8886 5.6700 6.6700 3.3700 5.2800 -1.86%
2009 5.0182 5.1000 7.6600 2.9000 5.3800 10.02%
2008 9.3999 12.9800 14.8300 3.5000 4.8900 -61.62%
2007 14.3258 14.5700 18.6500 10.0500 12.7400 -10.72%
2006 12.8201 12.5500 16.0000 9.3000 14.2700 14.90%
2005 15.4169 19.3000 19.3000 12.4200 12.4200 -36.21%
2004 16.2483 17.9500 20.4500 11.7100 19.4700 8.71%
2003 17.7648 14.6000 28.4300 11.5200 17.9100 27.93%
2002 16.6054 24.5500 25.7200 11.6500 14.0000 -40.43%
2001 22.9783 21.8100 34.9800 13.9500 23.5000 -5.55%
2000 53.9979 44.0000 122.0000 20.4400 24.8800 -45.91%
1999 17.7067 10.3800 46.8800 8.1250 46.0000 346.17%
1998 12.2603 14.6300 16.2500 6.5000 10.3100 -29.53%
1997 15.9713 18.5000 20.6300 13.0000 14.6300 -19.26%
1996 17.3435 19.7500 21.1300 14.2500 18.1200 -5.87%
1995 14.2192 11.3800 23.7500 9.6250 19.2500 72.96%
1994 12.4075 16.0000 19.3800 7.7500 11.1300 -29.91%
1993 10.8082 7.7500 19.8800 6.5000 15.8800 115.32%
1992 5.0900 3.3700 7.5000 3.2500 7.3750 96.67%
1991 1.6484 1.8800 7.8800 0.5000 3.7500 76.06%
1990 3.0223 3.8700 4.5000 1.7500 2.1300 -41.16%
1989 3.6294 3.1300 4.8700 2.6300 3.6200 11.38%
1988 3.9506 4.0000 4.8700 2.5000 3.2500 -13.33%
1987 8.4392 8.7500 12.1200 3.2500 3.7500 -57.14%
1986 12.7321 12.1200 18.7500 8.3800 8.7500 -29.26%
1985 14.1660 15.2500 21.0000 10.3700 12.3700 -17.53%
1984 16.3823 25.6200 26.2500 12.2500 15.0000 -39.69%
1983 24.7116 16.2467 33.5000 16.2467 24.8700 40.77%
1982 10.3396 10.5000 17.6667 5.5000 17.6667 66.98%
1981 9.2933 3.6233 15.0800 3.4567 10.5800 192.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.154B $0.081B
Enzo Biochem, Inc. develops, manufactures and markets health care products based on molecular biology and genetic engineering techniques, and also provides diagnostic services to the medical community. The business activities of the company are performed by one of the company's three wholly-owned subsidiaries--Enzo Diagnostics, Inc., Enzo Therapeutics, Inc., and Enzo Clinical Labs, Inc. The primary focus of the company's research is the development of products based on two technology platforms -- genetic modulation and immune modulation.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $122.075B 13.90
Gilead Sciences (GILD) United States $82.611B 10.15
CSL (CSLLY) Australia $77.981B 0.00
Celgene (CELG) United States $72.150B 11.16
Vertex Pharmaceuticals (VRTX) United States $45.680B 49.37
Illumina (ILMN) United States $45.651B 53.64
Biogen (BIIB) United States $41.611B 7.39
Regeneron Pharmaceuticals (REGN) United States $33.122B 15.03
Alexion Pharmaceuticals (ALXN) United States $22.420B 11.82
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $18.379B 0.00
Incyte (INCY) United States $16.653B 49.01
Seattle Genetics (SGEN) United States $13.898B 0.00
Genmab (GNMSF) Denmark $12.636B 70.88
Exact Sciences (EXAS) United States $12.611B 0.00
BioMarin Pharmaceutical (BMRN) United States $12.186B 0.00
Bio-Rad Laboratories (BIO.B) United States $10.175B 54.54
Alnylam Pharmaceuticals (ALNY) United States $9.106B 0.00
Galapagos (GLPG) Belgium $8.936B 0.00
Bio-Techne Corp (TECH) United States $7.635B 52.75
Sarepta Therapeutics (SRPT) United States $6.500B 0.00
QIAGEN (QGEN) Netherlands $6.355B 20.87
BeiGene (BGNE) Cayman Islands $6.328B 0.00
Guardant Health (GH) United States $6.299B 0.00
Amarin (AMRN) Ireland $5.855B 0.00
ACADIA Pharmaceuticals (ACAD) United States $5.777B 0.00
Horizon Therapeutics Public (HZNP) Ireland $5.310B 13.50
Reata Pharmaceuticals (RETA) United States $5.214B 0.00
Exelixis (EXEL) United States $5.149B 13.39
Bluebird Bio (BLUE) United States $5.048B 0.00
Moderna (MRNA) United States $4.801B 0.00
China Biologic Products (CBPO) China $4.553B 28.42
ARGENX SE-ADR (ARGX) Netherlands $4.494B 0.00
Medicines (MDCO) United States $4.443B 0.00
Ascendis Pharma (ASND) Denmark $4.217B 0.00
Repligen (RGEN) United States $4.084B 79.26
Spark Therapeutics (ONCE) United States $3.887B 0.00
Blueprint Medicines (BPMC) United States $3.673B 0.00
MorphoSys AG (MOR) Germany $3.482B 0.00
Mirati Therapeutics (MRTX) United States $3.422B 0.00
Immunomedics (IMMU) United States $3.045B 0.00
Emergent Biosolutions (EBS) United States $2.795B 41.99
Alkermes (ALKS) Ireland $2.786B 0.00
Genmab (GMAB) Denmark $2.701B 0.00
Genomic Health (GHDX) United States $2.632B 49.36
MyoKardia (MYOK) United States $2.625B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.532B 0.00
Arena Pharmaceuticals (ARNA) United States $2.437B 5.24
Halozyme Therapeutics (HALO) United States $2.312B 0.00
Acceleron Pharma (XLRN) United States $2.279B 0.00
Myriad Genetics (MYGN) United States $2.263B 23.58
RA PHARMCTL INC (RARX) United States $2.198B 0.00
NeoGenomics (NEO) United States $2.122B 113.50
Intercept Pharmaceuticals (ICPT) United States $2.106B 0.00
Amicus Therapeutics (FOLD) United States $2.083B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $2.072B 0.00
Ligand Pharmaceuticals (LGND) United States $2.057B 26.00
Cambrex (CBM) United States $2.002B 25.32
Zai Lab (ZLAB) China $1.983B 0.00
Akcea Therapeutics (AKCA) United States $1.761B 0.00
UniQure (QURE) Netherlands $1.674B 0.00
Alder BioPharmaceuticals (ALDR) United States $1.585B 0.00
Insmed (INSM) United States $1.564B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.504B 0.00
Denali Therapeutics (DNLI) United States $1.451B 0.00
REGENXBIO (RGNX) United States $1.437B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.397B 0.00
Coherus BioSciences (CHRS) United States $1.339B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.210B 0.00
Zymeworks (ZYME) Canada $1.176B 0.00
Innoviva (INVA) United States $1.107B 3.20
Dicerna Pharmaceuticals (DRNA) United States $1.080B 0.00
Alector (ALEC) United States $1.036B 0.00
AnaptysBio (ANAB) United States $1.009B 0.00
Editas Medicine (EDIT) United States $1.008B 0.00
Sangamo Therapeutics (SGMO) United States $0.998B 0.00
Fate Therapeutics (FATE) United States $0.960B 0.00
Epizyme (EPZM) United States $0.953B 0.00
ANI Pharmaceuticals (ANIP) United States $0.888B 14.83
Achillion Pharmaceuticals (ACHN) United States $0.866B 0.00
Zealand Pharma (ZEAL) Denmark $0.865B 9.71
BAVARIAN NORDIC (BVNRY) Denmark $0.856B 0.00
Athenex (ATNX) United States $0.835B 0.00
Codexis (CDXS) United States $0.808B 0.00
Twist Bioscience (TWST) United States $0.806B 0.00
Anika Therapeutics (ANIK) United States $0.803B 28.43
Cara Therapeutics (CARA) United States $0.788B 0.00
Principia Biopharma (PRNB) United States $0.761B 394.00
Vanda Pharmaceuticals (VNDA) United States $0.729B 26.31
Pharming Group (PHGUF) Netherlands $0.724B 0.00
Zealand Pharma (ZLDPF) Denmark $0.722B 0.00
WAVE Life Sciences (WVE) Singapore $0.721B 0.00
Vericel (VCEL) United States $0.684B 0.00
Revance Therapeutics (RVNC) United States $0.676B 0.00
Cytokineticsorporated (CYTK) United States $0.665B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.644B 0.00
Mesoblast (MESO) Australia $0.619B 0.00
Heska (HSKA) United States $0.596B 77.27
GENFIT S.A (GNFT) France $0.560B 0.00
MiMedx (MDXG) United States $0.556B 0.00
Intellia Therapeutics (NTLA) United States $0.555B 0.00
Arvinas (ARVN) United States $0.524B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.519B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.502B 0.00
PHARMA MAR SA (PHMMF) Spain $0.494B 0.00
Retrophin (RTRX) United States $0.491B 0.00
DBV Technologies S.A (DBVT) France $0.474B 0.00
Intra-Cellular Therapies (ITCI) United States $0.469B 0.00
UROGEN PHARMA (URGN) United States $0.468B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.462B 0.00
BioDelivery Sciences (BDSI) United States $0.461B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
Adverum Biotechnologies (ADVM) United States $0.454B 0.00
Cellectis S.A (CLLS) France $0.448B 0.00
Stemline Therapeutics (STML) United States $0.396B 0.00
Bellus Health (BLU) Canada $0.393B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.387B 0.00
Arcus Biosciences (RCUS) United States $0.386B 0.00
Merus (MRUS) Netherlands $0.376B 0.00
Agenus (AGEN) United States $0.368B 0.00
Kadmon Holdings (KDMN) United States $0.364B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.346B 0.00
Precision BioSciences (DTIL) United States $0.345B 0.00
AC Immune SA (ACIU) Switzerland $0.334B 24.75
CytomX Therapeutics (CTMX) United States $0.323B 0.00
Prothena (PRTA) Ireland $0.320B 0.00
Protagonist Therapeutics (PTGX) United States $0.317B 0.00
Avid Bioservices (CDMO) United States $0.299B 0.00
Gritstone Oncology (GRTS) United States $0.298B 0.00
Syros Pharmaceuticals (SYRS) United States $0.295B 0.00
Kindred Biosciences (KIN) United States $0.292B 0.00
Cel-Sci (CVM) United States $0.289B 0.00
Cellular Biomedicine (CBMG) United States $0.287B 0.00
Pfenex (PFNX) United States $0.281B 0.00
Geron (GERN) United States $0.281B 0.00
Scholar Rock Holding (SRRK) United States $0.280B 0.00
Starpharma Holdings (SPHRY) Australia $0.279B 0.00
PDL BioPharma (PDLI) United States $0.278B 7.15
Dynavax Technologies (DVAX) United States $0.276B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.271B 0.00
Biofrontera AG (BFRA) Germany $0.265B 395.33
Theratechnologies (THTX) Canada $0.263B 0.00
ADMA Biologics Inc (ADMA) United States $0.262B 0.00
Puma Biotechnology (PBYI) United States $0.260B 0.00
Seres Therapeutics (MCRB) United States $0.243B 0.00
MannKind (MNKD) United States $0.243B 0.00
Inovio Pharmaceuticals (INO) United States $0.234B 0.00
OSMOTICA PHARM (OSMT) United States $0.232B 0.00
Sutro Biopharma (STRO) United States $0.230B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.230B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.228B 0.00
Albireo Pharma (ALBO) United States $0.227B 0.00
Sorrento Therapeutics (SRNE) United States $0.219B 0.00
Kamada (KMDA) Israel $0.213B 8.14
Spero Therapeutics (SPRO) United States $0.212B 0.00
Athersys (ATHX) United States $0.211B 0.00
Exicure (XCUR) United States $0.205B 0.00
Compugen (CGEN) Israel $0.205B 0.00
POXEL SA FRANCE (PXXLF) France $0.204B 0.00
Clovis Oncology (CLVS) United States $0.200B 0.00
ChromaDex (CDXC) United States $0.198B 0.00
Affimed (AFMD) Germany $0.191B 0.00
Palatin Technologies (PTN) United States $0.190B 5.57
Syndax Pharmaceuticals (SNDX) United States $0.189B 0.00
Prometic Life Sciences (PFSCF) Canada $0.177B 0.00
Dyadic (DYAI) United States $0.177B 0.00
Nicox SA (NICXF) France $0.175B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.170B 0.00
Newron Pharmaceuticals SpA (NWPHF) $0.165B 0.00
Senesco Technologies (ELOX) United States $0.164B 0.00
Cue Biopharma (CUE) United States $0.163B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.162B 0.00
XOMA (XOMA) United States $0.161B 0.00
Cerecor (CERC) United States $0.153B 0.00
Arsanis (XFOR) United States $0.153B 0.00
Five Prime Therapeutics (FPRX) United States $0.150B 0.00
CorMedix Inc (CRMD) United States $0.148B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.148B 0.00
Alcobra (ARCT) United States $0.146B 0.00
BioTime (LCTX) United States $0.144B 9.60
Northwest Biotherapeutics (NWBO) United States $0.134B 0.00
Acorda Therapeutics (ACOR) United States $0.124B 0.00
SESEN BIO, INC (SESN) United States $0.121B 0.00
NantKwest (NK) United States $0.119B 0.00
Emmaus Life Sciences (EMMA) United States $0.118B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.117B 0.00
PHASEBIO PHARMA (PHAS) United States $0.116B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.113B 0.00
Abeona Therapeutics (ABEO) United States $0.111B 0.00
Novavax (NVAX) United States $0.111B 0.00
Menlo Therapeutics (MNLO) United States $0.110B 0.00
Aptinyx (APTX) United States $0.109B 0.00
Strongbridge Biopharma (SBBP) United States $0.109B 4.47
Adaptimmune Therapeutics (ADAP) United Kingdom $0.105B 0.00
Windtree Therapeutics (WINT) United States $0.103B 0.00
OvaScience (MLND) United States $0.097B 0.00
Celyad SA (CYAD) Belgium $0.097B 0.00
VBI Vaccines (VBIV) United States $0.096B 0.00
Fortress Biotech (FBIO) United States $0.090B 0.00
Trevena (TRVN) United States $0.089B 0.00
Liquidia Technologies (LQDA) United States $0.089B 0.00
Antibe Therapeutics (ATBPF) Canada $0.087B 0.00
Aduro Biotech (ADRO) United States $0.087B 0.00
Adocia (ADOCY) France $0.086B 0.00
Verastem (VSTM) United States $0.084B 0.00
Vaccinex (VCNX) United States $0.083B 0.00
Mersana Therapeutics (MRSN) United States $0.079B 0.00
Idera Pharmaceuticals (IDRA) United States $0.078B 0.00
Checkpoint Therapeutics (CKPT) United States $0.078B 0.00
VTv Therapeutics (VTVT) United States $0.077B 0.00
Aquinox Pharmaceuticals (NLTX) Canada $0.077B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.074B 0.00
ARAVIVE, INC (ARAV) United States $0.073B 0.00
Prima BioMed (IMMP) Australia $0.072B 0.00
Curis (CRIS) United States $0.071B 0.00
Synlogic (SYBX) United States $0.070B 0.00
Catalyst Biosciences (CBIO) United States $0.067B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.065B 0.00
Selecta Biosciences (SELB) United States $0.063B 0.00
Orgenesis (ORGS) United States $0.060B 21.82
AquaBounty Technologies (AQB) United States $0.057B 0.00
Pluristem Therapeutics (PSTI) Israel $0.057B 0.00
Applied Genetic Technologies (AGTC) United States $0.057B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.056B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.056B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.054B 0.00
Arbutus Biopharma (ABUS) Canada $0.053B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.051B 0.00
Unum Therapeutics (UMRX) United States $0.051B 0.00
VistaGen Therapeutics (VTGN) United States $0.050B 0.00
AIT Therapeutics (XAIR) United States $0.048B 0.00
NewLink Genetics (NLNK) United States $0.047B 0.00
Protalix BioTherapeutics (PLX) Israel $0.047B 0.00
Vascular Biogenics (VBLT) Israel $0.047B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.047B 0.00
VIVUS (VVUS) United States $0.044B 0.00
Evogene (EVGN) Israel $0.042B 0.00
AmpliPhi Biosciences (ARMP) United States $0.042B 0.00
Ophthotech (ISEE) United States $0.041B 0.00
Stellar Biotechnologies (EDSA) Canada $0.038B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.037B 0.00
Proteostasis Therapeutics (PTI) United States $0.037B 0.00
Organovo Holdings (ONVO) United States $0.037B 0.00
Oncobiologics (OTLK) United States $0.037B 0.00
Celsion (CLSN) United States $0.036B 0.00
Celldex Therapeutics (CLDX) United States $0.036B 0.00
DiaMedica Therapeutics (DMAC) United States $0.031B 0.00
Clearside Biomedical (CLSD) United States $0.031B 0.00
Aptevo Therapeutics (APVO) United States $0.029B 0.00
Signal Genetics (MGEN) United States $0.029B 0.00
Fibrocell Science Inc (FCSC) United States $0.029B 9.87
BioCardia (BCDA) United States $0.029B 0.00
Entera Bio (ENTX) Israel $0.027B 0.00
Alimera Sciences (ALIM) United States $0.026B 0.00
Caladrius Biosciences (CLBS) United States $0.024B 0.00
Aytu Bioscience (AYTU) United States $0.022B 0.00
Apricus Biosciences (SEEL) United States $0.021B 0.00
Novogen (KZIA) Australia $0.021B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.020B 0.00
AEterna Zentaris (AEZS) United States $0.020B 0.00
Soligenix (SNGX) United States $0.019B 0.00
CollPlant Holdings (CLGN) Israel $0.017B 0.00
Prana Biotechnology (ATHE) Australia $0.017B 0.00
Bionano Genomics (BNGO) United States $0.015B 0.00
TOCAGEN INC (TOCA) United States $0.014B 0.00
Pulmatrix (PULM) United States $0.014B 0.00
MYOS RENS Technology (MYOS) United States $0.013B 0.00
IBio (IBIO) United States $0.012B 0.00
IMMURON (IMRN) Australia $0.012B 0.00
Cleveland BioLabs (CBLI) United States $0.010B 0.00
TRACON Pharmaceuticals (TCON) United States $0.010B 0.00
Genetic Technologies (GENE) Australia $0.009B 0.00
Benitec Biopharma (BNTC) Australia $0.009B 0.00
TrovaGene (TROV) United States $0.007B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.006B 0.00
Advaxis (ADXS) United States $0.006B 0.00
BioPharmX (BPMX) United States $0.005B 0.00
Titan Pharmaceuticals (TTNP) United States $0.003B 0.00
Neuralstem (CUR) United States $0.003B 0.00